{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:47Z","timestamp":1787026667483,"version":"build-2736575974"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473154"],"award-info":[{"award-number":["82473154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates that arise in non-lymphoid tissues under chronic inflammatory conditions and during tumor development. Although TLS have often been associated with a favorable prognosis and enhanced therapeutic responsiveness, their biological and clinical significance in breast cancer is highly heterogeneous and cannot be adequately captured by a simple TLS-positive versus TLS-negative classification. In this review, we summarize the structural organization and developmental stages of TLS, with an emphasis on the functional relevance of maturation, including germinal center formation. We further discuss current concepts regarding the mechanisms driving TLS initiation and maturation, including stromal activation, chemokine-guided immune cell recruitment, and high endothelial venule-mediated lymphocyte trafficking. In addition, we examine the major dimensions of TLS heterogeneity in breast cancer, including differences in maturity, spatial location, molecular subtype, and immune cellular composition, and discuss how these variables shape antitumor, immunoregulatory, and context-dependent TLS functions. We also evaluate the current approaches for TLS identification and classification, highlighting the strengths and limitations of histopathology, immunophenotyping, multiplex imaging, and transcriptomic inference. Finally, we discuss the prognostic and predictive relevance of TLS in breast cancer, the barriers limiting its clinical translation, and key priorities for future research. Overall, TLS status represents a promising but context-dependent biomarker and potential therapeutic intermediate whose interpretation requires standardized classification and a deeper mechanistic understanding.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1827875","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:42:07Z","timestamp":1780378927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Tertiary lymphoid structures in breast cancer: formation, immune functions and clinical implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Wenting","family":"Dong","sequence":"first","affiliation":[{"name":"Division of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Ai","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, School of Medicine, Southeast University","place":["Nanjing, China"]},{"name":"Division of Gastric Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Yao","sequence":"additional","affiliation":[{"name":"Division of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, School of Medicine, Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J-Peking"},{"key":"B3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-019-0975-5","article-title":"Exosomes in the tumor microenvironment as mediators of cancer therapy resistance","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.3390\/cancers13164233","article-title":"Tumor microenvironment in breast cancer-updates on therapeutic implications and pathologic assessment","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3892\/ol.2021.13097","article-title":"Tertiary lymphoid structure and B-cell-related pathways: a potential target in tumor immunotherapy","volume":"22","author":"Qin","year":"2021","journal-title":"Oncol Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061120","article-title":"Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development","volume":"204","author":"Aspord","year":"2007","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000000483","article-title":"Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study","volume":"109","author":"Mao","year":"2023","journal-title":"Int J Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1900508","DOI":"10.1080\/2162402X.2021.1900508","article-title":"Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies","volume":"10","author":"N","year":"2021","journal-title":"Oncoimmunology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41416-024-02917-y","article-title":"Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer","volume":"132","author":"Wang","year":"2025","journal-title":"Br J Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e009232","DOI":"10.1136\/jitc-2024-009232","article-title":"Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis","volume":"12","author":"Zhao","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/cancers15051517","article-title":"B cells in breast cancer pathology","volume":"15","author":"Li","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/bctt.s426121","article-title":"Research progress on molecular subtyping and modern treatment of triple-negative breast cancer","volume":"15","author":"Tong","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01830","article-title":"Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease","volume":"8","author":"Colbeck","year":"2017","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.04.009","article-title":"Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells","volume":"26","author":"Meier","year":"2007","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/cancers14020294","article-title":"Potential role of CXCL13\/CXCR5 signaling in immune checkpoint inhibitor treatment in cancer","volume":"14","author":"Hsieh","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.2139\/ssrn.3575119","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.36401\/jipo-22-10","article-title":"The role of interleukin-7 in the formation of tertiary lymphoid structures and their prognostic value in gastrointestinal cancers","volume":"5","author":"Ware","year":"2022","journal-title":"J Immunother Precis Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/s41467-022-29753-z","article-title":"T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy","volume":"13","author":"Garaud","year":"2022","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: an intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11720","DOI":"10.1038\/s41598-018-29604-2","article-title":"ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes","volume":"8","author":"Figenschau","year":"2018","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-021-09792-8","article-title":"High endothelial venules (HEVs) in immunity, inflammation and cancer","volume":"24","author":"Blanchard","year":"2021","journal-title":"Angiogenesis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2021.0029","article-title":"Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies","volume":"18","author":"Zhao","year":"2021","journal-title":"Cancer Biol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1346","article-title":"Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy","volume":"13","author":"Wang","year":"2023","journal-title":"Clin Transl Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1978","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Silina","year":"2018","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1257452","article-title":"Tumor-infiltrating lymphocyte composition, organization and PD-1\/ PD-L1 expression are linked in breast cancer","volume":"6","author":"Buisseret","year":"2017","journal-title":"Oncoimmunology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694079","article-title":"The 12-CK score: global measurement of tertiary lymphoid structures","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"13542","DOI":"10.1038\/s41598-023-40042-7","article-title":"Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02407-8","article-title":"The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer","volume":"68","author":"Sofopoulos","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","article-title":"Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis","volume":"32","author":"Lee","year":"2019","journal-title":"Mod Pathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13058-019-1148-6","article-title":"Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications","volume":"21","author":"J\u00e9z\u00e9quel","year":"2019","journal-title":"Breast Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4143\/crt.2016.215","article-title":"Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer","volume":"49","author":"Song","year":"2017","journal-title":"Cancer Res Treat"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11415","article-title":"CD11c-positive dendritic cells in triple-negative breast cancer","volume":"32","author":"Lee","year":"2018","journal-title":"In Vivo"},{"key":"B44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","article-title":"Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/jci67428","article-title":"CD4(+) follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e006425","DOI":"10.1136\/jitc-2022-006425","article-title":"Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases","volume":"11","author":"Zhang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.017","article-title":"B cells in the tumor microenvironment: multi-faceted organizers, regulators, and effectors of anti-tumor immunity","volume":"41","author":"Laumont","year":"2023","journal-title":"Cancer Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.11.066","article-title":"FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer","volume":"39","author":"De Silva","year":"2019","journal-title":"EBioMedicine"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/his.14865","article-title":"Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters","volume":"82","author":"Zeng","year":"2023","journal-title":"Histopathology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-21-1130","article-title":"B cells and tertiary lymphoid structures: Friends or foes in cancer immunotherapy","volume":"28","author":"Lauss","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868155","article-title":"The presence of tertiary lymphoid structures provides new insight into the clinicopathological features and prognosis of patients with breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12935-021-02242-x","article-title":"Prognostic impact of tertiary lymphoid structures in breast cancer prognosis: a systematic review and meta-analysis","volume":"21","author":"Zhang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6864","article-title":"Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer","volume":"13","author":"Gu","year":"2023","journal-title":"Cancer Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12447","article-title":"Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer","volume":"43","author":"Bertucci","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/cancers15041262","article-title":"CD169+ macrophages in primary breast tumors associate with tertiary lymphoid structures, T(regs) and a worse prognosis for patients with advanced breast cancer","volume":"15","author":"Briem","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/cells12081176","article-title":"Tertiary lymphoid structures (TLSs) and stromal blood vessels have significant and heterogeneous impact on recurrence, lymphovascular and perineural invasion amongst breast cancer molecular subtypes","volume":"12","author":"Barb","year":"2023","journal-title":"Cells"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0029","article-title":"Distinct tertiary lymphoid structure associations and their prognostic relevance in HER2 positive and negative breast cancers","volume":"22","author":"Liu","year":"2017","journal-title":"Oncologist"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05548-y","article-title":"Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers","volume":"180","author":"Seow","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1534928","article-title":"Development of a tertiary lymphoid structure-based prognostic model for breast cancer: Integrating single-cell sequencing and machine learning to enhance patient outcomes","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","article-title":"Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1507371","article-title":"Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: Integrated analysis with the tumor microenvironment and clinicopathological features","volume":"15","author":"Boissiere-Michot","year":"2024","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674565","article-title":"Tertiary lymphoid structures as a predictive biomarker of response to cancer immunotherapies","volume":"12","author":"Trub","year":"2021","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.56347","article-title":"Relationship between tertiary lymphoid structure and the prognosis and clinicopathologic characteristics in solid tumors","volume":"18","author":"Zhao","year":"2021","journal-title":"Int J Med Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698604","article-title":"Tumor-associated tertiary lymphoid structures: From basic and clinical knowledge to therapeutic manipulation","volume":"12","author":"Domblides","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1827875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:42:09Z","timestamp":1780378929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1827875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2026.1827875"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1827875","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"article-number":"1827875"}}